Washington HB 2145: Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.

Status: Referred to Rules 2 Review. (as of 2026-02-09)

State: Washington · Session: 2025-2026 · Bill: HB 2145

Sponsors: Thai, Berg, Bergquist, Bernbaum, Berry, Cortes, Davis, Doglio, Duerr, Entenman, Farivar, Fey, Fosse, Goodman, Gregerson, Hall, Hill, Kloba, Lekanoff, Macri, Mena, Morgan, Obras, Ormsby, Parshley

View Washington HB 2145 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.